Gene: Pcdh20 (protocadherin 20) Rattus norvegicus
Analyze
Symbol:
Pcdh20
Name:
protocadherin 20
Description:
Predicted to have calcium ion binding activity. Predicted to be involved in cell adhesion. Predicted to localize to the integral component of plasma membrane. Orthologous to human PCDH20 (protocadherin 20); INTERACTS WITH 6-propyl-2-thiouracil; bisphenol A; DDT.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Also known as:
LOC306081; protocadherin-20
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
PCDH20 (protocadherin 20) HGNC
Ensembl, HomoloGene, Inparanoid, NCBI, OMA, Panther, Treefam
Mus musculus (house mouse):
Pcdh20 (protocadherin 20) HGNC
Treefam, NCBI, OMA, HomoloGene, Inparanoid, Panther, Ensembl
Chinchilla lanigera (long-tailed chinchilla):
Pcdh20 (protocadherin 20) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
PCDH20 (protocadherin 20) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
PCDH20 (protocadherin 20) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Pcdh20 (protocadherin 20) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
PCDH20 (protocadherin 20) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
PCDH9 (protocadherin 9) HGNC
OrthoMCL
Homo sapiens (human):
PCDH11X (protocadherin 11 X-linked) HGNC
OrthoMCL
Alliance orthologs 3
Homo sapiens (human):
PCDH20 (protocadherin 20)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Mus musculus (house mouse):
Pcdh20 (protocadherin 20)
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, TreeFam)
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 15 71,772,777 - 71,779,033 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 15 71,772,777 - 71,779,033 (-) Ensembl Rnor_5.0 15 75,353,079 - 75,359,335 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 15 70,760,564 - 70,766,820 (-) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 15 70,777,005 - 70,782,599 (-) NCBI Celera 15 63,904,183 - 63,910,439 (-) NCBI Celera Cytogenetic Map 15 q12 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Gene-Chemical Interaction Annotations
3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1314838 6480464 tetrabromobisphenol A results in decreased expression of PCDH20 mRNA CTD PMID:25172293 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PCDH20 mRNA CTD PMID:24780913 8-bromo-3',5'-cyclic AMP decreases expression ISO RGD:1314837 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PCDH20 mRNA CTD PMID:22079614 all-trans-retinoic acid increases expression ISO RGD:1314837 6480464 Tretinoin results in increased expression of PCDH20 mRNA CTD PMID:21934132 , PMID:23724009 antirheumatic drug increases expression ISO RGD:1314837 6480464 Antirheumatic Agents results in increased expression of PCDH20 mRNA CTD PMID:24449571 arsenous acid decreases expression ISO RGD:1314837 6480464 Arsenic Trioxide results in decreased expression of PCDH20 mRNA CTD PMID:26705709 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of PCDH20 mRNA CTD PMID:26496021 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PCDH20 mRNA CTD PMID:31129395 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PCDH20 mRNA CTD PMID:25181051 bisphenol F decreases expression ISO RGD:1314838 6480464 bisphenol F results in decreased expression of PCDH20 mRNA CTD PMID:30951980 buta-1,3-diene increases expression ISO RGD:1314838 6480464 1, 3-butadiene results in increased expression of PCDH20 mRNA CTD PMID:29038090 cyclosporin A decreases expression ISO RGD:1314837 6480464 Cyclosporine results in decreased expression of PCDH20 mRNA CTD PMID:20106945 cytarabine decreases expression ISO RGD:1314837 6480464 Cytarabine results in decreased expression of PCDH20 mRNA CTD PMID:21198554 DDT decreases expression EXP 6480464 DDT results in decreased expression of PCDH20 mRNA CTD PMID:30207508 diarsenic trioxide decreases expression ISO RGD:1314837 6480464 Arsenic Trioxide results in decreased expression of PCDH20 mRNA CTD PMID:26705709 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PCDH20 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1314837 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1314837 6480464 Doxorubicin results in decreased expression of PCDH20 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PCDH20 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1314837 6480464 entinostat results in increased expression of PCDH20 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1314837 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA CTD PMID:27188386 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of PCDH20 mRNA CTD PMID:24915197 medroxyprogesterone acetate decreases expression ISO RGD:1314837 6480464 Medroxyprogesterone Acetate results in decreased expression of PCDH20 mRNA CTD PMID:20843944 mercury dibromide increases expression ISO RGD:1314837 6480464 mercuric bromide results in increased expression of PCDH20 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1314837 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA CTD PMID:27188386 methylmercury chloride decreases expression ISO RGD:1314837 6480464 methylmercuric chloride results in decreased expression of PCDH20 mRNA CTD PMID:23179753 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1314837 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of PCDH20 mRNA CTD PMID:24810058 nickel atom decreases expression ISO RGD:1314837 6480464 Nickel results in decreased expression of PCDH20 mRNA CTD PMID:25583101 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of PCDH20 mRNA CTD PMID:26720608 panobinostat multiple interactions ISO RGD:1314837 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1314837 6480464 panobinostat results in increased expression of PCDH20 mRNA CTD PMID:26272509 phenylmercury acetate increases expression ISO RGD:1314837 6480464 Phenylmercuric Acetate results in increased expression of PCDH20 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1314837 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1314838 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PCDH20 mRNA CTD PMID:19710929 rotenone decreases expression ISO RGD:1314837 6480464 Rotenone results in decreased expression of PCDH20 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:1314837 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of PCDH20 mRNA CTD PMID:26496021 trichostatin A increases expression ISO RGD:1314837 6480464 trichostatin A results in increased expression of PCDH20 mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:1314837 6480464 Triclosan results in decreased expression of PCDH20 mRNA CTD PMID:30510588 valproic acid affects expression ISO RGD:1314838 6480464 Valproic Acid affects the expression of PCDH20 mRNA CTD PMID:17963808 valproic acid affects expression ISO RGD:1314837 6480464 Valproic Acid affects the expression of PCDH20 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1314837 6480464 Valproic Acid results in increased expression of PCDH20 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO RGD:1314837 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PCDH20 mRNA CTD PMID:27188386 zoledronic acid decreases expression ISO RGD:1314837 6480464 zoledronic acid results in decreased expression of PCDH20 mRNA CTD PMID:24714768
Gene Ontology Annotations
61477 Aia4 Adjuvant induced arthritis QTL 4 3 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 15 62596410 99372139 Rat 61424 Scl1 Serum cholesterol level QTL 1 7.7 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 15 18513913 88036354 Rat 631516 Gluco31 Glucose level QTL 31 7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 15 62596410 103164962 Rat 631655 Bp126 Blood pressure QTL 126 4 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 15 65520564 110520564 Rat 724545 Niddm54 Non-insulin dependent diabetes mellitus QTL 54 0.02 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 15 57528970 81263988 Rat 1300144 Rf23 Renal function QTL 23 3.61 renal blood flow trait (VT:2000006) absolute change in renal vascular resistance (CMO:0001900) 15 43097470 106550657 Rat 1331729 Rf42 Renal function QTL 42 3.071 kidney blood vessel physiology trait (VT:0100012) absolute change in renal blood flow rate (CMO:0001168) 15 18093208 81255430 Rat 1576315 Schws6 Schwannoma susceptibility QTL 6 0.0069 nervous system integrity trait (VT:0010566) post-insult time of death (CMO:0002005) 15 61447766 106447766 Rat 1582214 Stl21 Serum triglyceride level QTL 21 3.1 0.022 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 15 33219101 89640841 Rat 1582227 Gluco30 Glucose level QTL 30 3.6 0.0003 blood glucose amount (VT:0000188) absolute change in blood glucose level area under curve (CMO:0002034) 15 33219101 89640841 Rat 1582228 Epfw3 Epididymal fat weight QTL 3 4.1 0.0002 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 15 33219101 89640841 Rat 1582242 Gluco28 Glucose level QTL 28 3.3 0.0008 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 15 33219101 89640841 Rat 1582244 Bw79 Body weight QTL 79 4 0.0002 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 15 33219101 89640841 Rat 1578646 Bmd18 Bone mineral density QTL 18 5.2 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 15 26381041 106550657 Rat 1578647 Bmd17 Bone mineral density QTL 17 4 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 15 26381041 106550657 Rat 1578660 Bss19 Bone structure and strength QTL 19 4.3 femur morphology trait (VT:0000559) bone trabecular cross-sectional area (CMO:0002311) 15 26381041 106550657 Rat 1598828 Glom14 Glomerulus QTL 14 2.5 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 15 41068094 86068094 Rat 2313080 Bss65 Bone structure and strength QTL 65 3.9 0.0001 long bone metaphysis morphology trait (VT:0000133) tibia midshaft total cross-sectional area (CMO:0001715) 15 68366508 81255430 Rat 2293686 Bmd36 Bone mineral density QTL 36 7.4 0.0001 femur strength trait (VT:0010010) femoral neck ultimate force (CMO:0001703) 15 39749557 79033707 Rat 2293691 Bmd37 Bone mineral density QTL 37 6.6 0.0001 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 15 39749557 79033707 Rat 2317050 Aia24 Adjuvant induced arthritis QTL 24 2.06 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 15 59651151 81255430 Rat 2317750 Glom26 Glomerulus QTL 26 4.3 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 15 15492360 72568189 Rat 10054130 Srcrt8 Stress Responsive Cort QTL 8 2.18 0.0085 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 15 28709741 73709741 Rat
Predicted Target Of
Count of predictions: 356 Count of miRNA genes: 189 Interacting mature miRNAs: 258 Transcripts: ENSRNOT00000017765 Prediction methods: Miranda, Targetscan Result types: miRGate_prediction
Gene-Chemical Interaction Annotations
